Secukinumab (AIN457) is a high affinity, human monoclonal antibody targeted against interleukin (IL) -17A. Secukinumab is the first-in-class anti-IL-17 agent used for the research of plaque psoriasis, ankylosing spondylitis and psoriatic arthritis[1][2].
CAS Number
[1229022-83-6]
Smiles
[Secukinumab]
Target
Interleukin Related
Isoform
IL-17
Purity
99.2
Solubility
H2O
Storage Conditions
Store at 4°C for 2 years, do not freeze
Shipping Conditions
Isolate blue ice and the product with bubble pack to avoid direct contact